US FDA's devices centre urges voluntary eMDR ahead of regulation
This article was originally published in RAJ Devices
Executive Summary
The head of the US Food and Drug Administration’s devices centre is urging companies to begin voluntarily submitting adverse event reports under the electronic medical device reporting (eMDR) system. eMDR will become mandatory at some point in the future, although no set time frame has been given for this to happen.
You may also be interested in...
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
US FDA scrutiny of DTC genetic tests continues
The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.